HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bo Young Choi Selected Research

4- cyclohexylmethoxy- 5- nitrosopyrimidine- 2,6- diamine

11/2020Effects of Transient Receptor Potential Cation 5 (TRPC5) Inhibitor, NU6027, on Hippocampal Neuronal Death after Traumatic Brain Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bo Young Choi Research Topics

Disease

11Hypoglycemia (Reactive Hypoglycemia)
01/2022 - 01/2012
11Ischemia
11/2020 - 06/2012
10Cognitive Dysfunction
11/2020 - 06/2012
9Brain Injuries (Brain Injury)
01/2021 - 01/2013
9Traumatic Brain Injuries (Traumatic Brain Injury)
11/2020 - 05/2012
7Brain Ischemia (Cerebral Ischemia)
08/2020 - 01/2015
7Multiple Sclerosis
05/2020 - 06/2013
6Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2020 - 06/2013
6Epilepsy (Aura)
10/2018 - 10/2014
5Stroke (Strokes)
08/2020 - 01/2015
5Transient Ischemic Attack
08/2020 - 06/2012
4Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2017
4Seizures (Absence Seizure)
01/2020 - 01/2017
3Nervous System Diseases (Neurological Disorders)
05/2021 - 11/2020
3Dementia (Dementias)
12/2019 - 01/2017
3Neoplasms (Cancer)
05/2018 - 01/2016
3Temporal Lobe Epilepsy
11/2017 - 03/2013
2Inflammation (Inflammations)
01/2022 - 11/2020
2Ischemic Stroke
08/2020 - 01/2015
2Heart Arrest (Cardiac Arrest)
05/2017 - 02/2015
2Hypothermia
05/2017 - 02/2015
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017 - 01/2013
2Disease Progression
05/2015 - 01/2014
2Demyelinating Diseases (Demyelinating Disease)
05/2015 - 01/2014
1Wounds and Injuries (Trauma)
06/2022
1Necrosis
01/2022
1Anxiety Disorders (Anxiety Disorder)
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Tauopathies
01/2021
1Brain Diseases (Brain Disorder)
11/2020
1Edema (Dropsy)
11/2020
1Myocardial Infarction
08/2020
1Acidosis
06/2020
1Central Nervous System Diseases (CNS Diseases)
01/2020

Drug/Important Bio-Agent (IBA)

18ZincIBA
11/2020 - 01/2012
7Insulin (Novolin)FDA Link
01/2022 - 07/2012
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2012
5Neuroprotective AgentsIBA
01/2020 - 01/2015
4Superoxides (Superoxide)IBA
05/2021 - 06/2012
4Reactive Oxygen Species (Oxygen Radicals)IBA
05/2021 - 05/2015
4Therapeutic UsesIBA
01/2018 - 01/2015
4Pilocarpine (Ocusert)FDA LinkGeneric
11/2017 - 03/2013
4Myelin-Oligodendrocyte GlycoproteinIBA
10/2016 - 06/2013
4fluoro jadeIBA
02/2015 - 06/2012
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2022 - 01/2013
3CationsIBA
01/2022 - 08/2020
3NADPH Oxidases (NAD(P)H oxidase)IBA
05/2021 - 07/2012
3AntioxidantsIBA
08/2020 - 05/2018
3Glutathione (Reduced Glutathione)IBA
08/2020 - 10/2014
3zinc-binding protein (zinc binding protein)IBA
05/2020 - 10/2016
3Pyruvic Acid (Pyruvate)IBA
01/2019 - 01/2013
3Blood Glucose (Blood Sugar)IBA
01/2019 - 06/2012
3Adenosine Triphosphate (ATP)IBA
01/2019 - 06/2012
3NAD (NADH)IBA
01/2013 - 05/2012
2CalciumIBA
01/2022 - 08/2020
2Free RadicalsIBA
01/2022 - 05/2021
2tau Proteins (tau Protein)IBA
01/2021 - 01/2020
2Acetylcysteine (Siran)FDA LinkGeneric
08/2020 - 02/2017
2Excitatory Amino AcidsIBA
08/2020 - 01/2018
2Cysteine (L-Cysteine)FDA Link
08/2020 - 01/2016
2SodiumIBA
06/2020 - 06/2012
2Chelating AgentsIBA
05/2020 - 06/2013
2Dichloroacetic AcidIBA
01/2019 - 01/2018
2acetovanillone (apocynin)IBA
10/2018 - 05/2015
2protocatechuic acidIBA
05/2018 - 11/2017
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2018 - 01/2017
2Immunoglobulin G (IgG)IBA
02/2015 - 03/2013
2PiwepIBA
01/2015 - 01/2014
1Pharmaceutical PreparationsIBA
06/2022
1CeramidesIBA
01/2022
1Imipramine (Janimine)FDA LinkGeneric
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2022
1LipidsIBA
01/2022
1NADP (NADPH)IBA
05/2021
1EnzymesIBA
05/2021
1HydrogelsIBA
01/2021
1Fibroins (Fibroin)IBA
01/2021
1Biocompatible Materials (Biomaterials)IBA
01/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1IonsIBA
11/2020
1Biological ProductsIBA
11/2020
14- cyclohexylmethoxy- 5- nitrosopyrimidine- 2,6- diamineIBA
11/2020
1Amiloride (Midamor)FDA LinkGeneric
06/2020
1HydrogenIBA
06/2020
1lipoxin A4IBA
03/2020
1InterleukinsIBA
03/2020
1Biomarkers (Surrogate Marker)IBA
03/2020
1cerebrolysinIBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
1Cholinergic Agents (Cholinergics)IBA
12/2019
1Oxidoreductases (Dehydrogenase)IBA
01/2019

Therapy/Procedure

6Intraperitoneal Injections
11/2017 - 06/2012
2Resuscitation
05/2017 - 02/2015
2Therapeutics
02/2015 - 01/2013
2Anesthesia
01/2013 - 07/2012
1Stem Cell Transplantation
01/2021
1Cell Transplantation
01/2021